179 related articles for article (PubMed ID: 427556)
1. Age-dependent effects of 6-hydroxydopamine on locomotor activity in the rat.
Erinoff L; MacPhail RC; Heller A; Seiden LS
Brain Res; 1979 Mar; 164():195-205. PubMed ID: 427556
[TBL] [Abstract][Full Text] [Related]
2. Magnitude and duration of hyperactivity following neonatal 6-hydroxydopamine is related to the extent of brain dopamine depletion.
Miller FE; Heffner TG; Kotake C; Seiden LS
Brain Res; 1981 Dec; 229(1):123-32. PubMed ID: 6796194
[TBL] [Abstract][Full Text] [Related]
3. Possible involvement of serotonergic neurons in the reduction of locomotor hyperactivity caused by amphetamine in neonatal rats depleted of brain dopamine.
Heffner TG; Seiden LS
Brain Res; 1982 Jul; 244(1):81-90. PubMed ID: 6288184
[TBL] [Abstract][Full Text] [Related]
4. Comparison of hyperactivity in adult rats induced by neonatal intraventricular 6-hydroxydopamine following pargyline or desmethylimipramine treatment.
Olds ME; Yuwiler A
Psychopharmacology (Berl); 1985; 87(4):484-9. PubMed ID: 3936107
[TBL] [Abstract][Full Text] [Related]
5. Intraventricular 6-hydroxydopamine in the newborn rat and locomotor responses to drugs in infancy: no support for the dopamine depletion model of minimal brain dysfunction.
Pappas BA; Gallivan JV; Dugas T; Saari M; Ings R
Psychopharmacology (Berl); 1980; 70(1):41-6. PubMed ID: 6775333
[TBL] [Abstract][Full Text] [Related]
6. Mesolimbicocortical dopamine terminal fields are necessary for normal locomotor and investigatory exploration in rats.
Fink JS; Smith GP
Brain Res; 1980 Oct; 199(2):359-84. PubMed ID: 7417789
[TBL] [Abstract][Full Text] [Related]
7. Depletion of catecholamines in the brain of rats differentially affects stimulation of locomotor activity by caffeine, D-amphetamine, and methylphenidate.
Finn IB; Iuvone PM; Holtzman SG
Neuropharmacology; 1990 Jul; 29(7):625-31. PubMed ID: 1974712
[TBL] [Abstract][Full Text] [Related]
8. The effect of water-deprivation on locomotor activity in rats treated with 6-hydroxydopamine.
Seiden LS; Pachman SH; Heffner TG; Shaughnessy RA; Vosmer G
Brain Res; 1985 Jul; 337(2):225-32. PubMed ID: 3928086
[TBL] [Abstract][Full Text] [Related]
9. Effect of manipulating central catecholamines on puberty and the surge of luteinizing hormone and gonadotropin releasing hormone induced by pregnant mare serum gonadotropin in female rats.
Sarkar DK; Smith GC; Fink G
Brain Res; 1981 Jun; 213(2):335-49. PubMed ID: 6113874
[TBL] [Abstract][Full Text] [Related]
10. Behavioural and biochemical effects of dopamine and noradrenaline depletion within the medial prefrontal cortex of the rat.
Carter CJ; Pycock CJ
Brain Res; 1980 Jun; 192(1):163-76. PubMed ID: 7189685
[TBL] [Abstract][Full Text] [Related]
11. Impaired acquisition of an operant response in young rats depleted of brain dopamine in neonatal life.
Heffner TG; Seiden LS
Psychopharmacology (Berl); 1983; 79(2-3):115-9. PubMed ID: 6405418
[TBL] [Abstract][Full Text] [Related]
12. Modification of different morphine actions by 6-hydroxydopamine and 6-hydroxydopamine plus desmethylimipramine.
Fuchs V; Coper H
Psychopharmacology (Berl); 1980 Feb; 67(2):181-8. PubMed ID: 6768093
[TBL] [Abstract][Full Text] [Related]
13. 6-hydroxydopamine treatments enhance behavioral responses to intracerebral microinjection of D1- and D2-dopamine agonists into nucleus accumbens and striatum without changing dopamine antagonist binding.
Breese GR; Duncan GE; Napier TC; Bondy SC; Iorio LC; Mueller RA
J Pharmacol Exp Ther; 1987 Jan; 240(1):167-76. PubMed ID: 3100767
[TBL] [Abstract][Full Text] [Related]
14. Variability among brain regions in the specificity of 6-hydroxydopamine (6-OHDA)-induced lesions.
Commins DL; Shaughnessy RA; Axt KJ; Vosmer G; Seiden LS
J Neural Transm; 1989; 77(2-3):197-210. PubMed ID: 2503586
[TBL] [Abstract][Full Text] [Related]
15. Depletion of central catecholamines alters amphetamine- and fenfluramine-induced taste aversions in the rat.
Lorden JF; Callahan M; Dawson R
J Comp Physiol Psychol; 1980 Feb; 94(1):99-114. PubMed ID: 7372855
[TBL] [Abstract][Full Text] [Related]
16. Catecholamine release by intracerebral perfusion of 6-hydroxydopamine and desipramine.
Martin GE; Myers RD; Newberg DC
Eur J Pharmacol; 1976 Apr; 36(2):299-311. PubMed ID: 1278225
[TBL] [Abstract][Full Text] [Related]
17. Norepinephrine stimulates behavioral activation in rats following depletion of nucleus accumbens dopamine.
Swerdlow NR; Koob GF
Pharmacol Biochem Behav; 1989 Jul; 33(3):595-9. PubMed ID: 2511575
[TBL] [Abstract][Full Text] [Related]
18. Pharmacological investigation on the role of dopamine in the rat locus coeruleus.
Milon H; McRae-Degueurce A
Neurosci Lett; 1982 Jun; 30(3):297-301. PubMed ID: 6810240
[TBL] [Abstract][Full Text] [Related]
19. Dopamine agonist-induced locomotor activity in rats treated with 6-hydroxydopamine at differing ages: functional supersensitivity of D-1 dopamine receptors in neonatally lesioned rats.
Breese GR; Napier TC; Mueller RA
J Pharmacol Exp Ther; 1985 Aug; 234(2):447-55. PubMed ID: 3926987
[TBL] [Abstract][Full Text] [Related]
20. Dopaminergic but not noradrenergic mediation of hyperactivity and performance deficits in the developing rat pup.
Shaywitz BA; Teicher MH; Cohen DJ; Anderson GM; Young JG; Levitt P
Psychopharmacology (Berl); 1984; 82(1-2):73-7. PubMed ID: 6420833
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
